QNRXNasdaqManufacturing

Quoin Pharmaceuticals, Ltd. (QNRX) earnings date, market-implied expected move, and options open interest by expiry

4.29

+0.27 · +6.72%

post 4.22 −1.63%

Closed15:59 ET

Open3.72Volume21,376Mkt cap$2.8M

Day3.72 – 4.2299%52-wk3.25 – 23.505%

QNRX

Quoin Pharmaceuticals, Ltd.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Nov 5

after close · in 2 days

est.Q3 FY26

Calendar

Next report

Last report

—

Largest filed tie

—

Largest filed tie

13F top-10 QoQ

+80.14%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

Top fund weight

—

Quoin Pharmaceuticals (QNRX) is expected to report on Nov 5 after close (estimated date).

Implied vs realized

No reported quarters.

Implied vs realized

Positioning

No open-interest data.

Positioning

Linked exposure

No linked exposure.

Linked exposure

Revenue flow

No filed income statement.

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 15:45 ET

Intraday

Event sensitivity

PCE ×1.61· ±7.6% vs ±4.7% · 20 releases

eventrelease day|move|up · n×base

PCEpersonal income & outlays±7.6%7 of 20×1.61

NFPjobs report±6.2%5 of 10×1.30

GDPgross domestic product±4.6%10 of 20×0.97

PPIproducer prices±4.2%3 of 11×0.89

CPROFcorporate profits±4.0%5 of 12×0.83

CPIconsumer prices±3.5%5 of 11×0.75

FOMCrate decision±3.0%12 of 24×0.64

Bar = avg |move| to ±8% · tick = ±4.7% avg day · ×base = |move| ÷ ±4.7% · min 6 releases

Earnings history

EPS -1.90 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	—	-1.90	—
Q1 FY26	—	-1.77	—
Q3 FY25	—	-6.71	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod